|
BKM-120
|
BKM120
|
1202777-78-3
|
|
RN-486
|
RN 486
|
1242156-23-5
|
|
Lomequatrib
|
|
|
|
Rocaqlamide
|
|
|
|
Y-27632
|
Y-27632二鹽酸鹽;4-[(1R)-1-氨基乙基]-N-(吡啶-4-基)環(huán)己烷-1-甲酰胺二鹽酸鹽
|
146986-50-7
|
|
Docetaxel
|
多烯他賽 ;多烯紫杉醇三水合物(非藥典標(biāo)準(zhǔn)品);多西紫杉醇;多西他塞;多似紫杉醇(無水);紫杉特爾;多希紫杉醇;多烯紫杉醇
|
114977-28-5
|
|
SCH-772984
|
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)對(duì)二氮己環(huán)-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺;1-(2-氧代-2-(4-(4-(嘧啶-2-基)苯基)哌嗪-1-基)乙基)吡咯烷-3-甲酸(R)-甲酯;(3R)-1-[2-氧代-2-[4-[4-(2-嘧啶基)苯基]-1-哌嗪基]乙基]-N-[3-(4-吡啶基)-1H-吲唑-5-基]-3-吡咯烷甲酰胺;(R)-1-(2-氧代-2-(4-(4-(2-嘧啶L)苯基)-L-哌嗪)乙基)-3-[N-
|
942183-80-4
|
|
AM-5992
|
|
|
|
CCT245737
|
CCT245737
|
1489389-18-5
|
|
IPI-549
|
IPI-549
|
1693758-51-8
|
|
PX-866
|
PX-866
|
502632-66-8
|
|
Sunitinib malate
|
N-(2-(二乙基氨基)乙基)-5-((Z)-(5-氟-1,2-二氫-2-氧代-3H-吲哚-3-亞基)甲基)-2,4-二甲基-1H-吡咯-3-甲酰胺 (2S)-羥基丁二酸鹽;蘋果酸舒尼替尼;蘇尼替尼蘋果酸鹽;SU11248; SUTENT;蘋果酸舒尼替尼鹽;N-(2-(二乙基氨基)乙基)-(5-氟-1,2-二氫-2-氧代-3H-吲哚-3-亞基)甲基-2,4-二甲基-1H-吡咯-3-羧酸酰胺
|
341031-54-7
|
|
PRI-724
|
PRI-724
|
1198780-43-6
|
|
G1T28(Trilaciclib)
|
|
|
|
AM-2282
|
星孢菌素;鏈霉菌屬十字孢堿;十字孢堿;鏈霉菌屬十字孢堿分子生物學(xué)試劑;十字孢堿,99+%;十字胞堿;星形孢菌素;星胞菌素
|
62996-74-1
|
|
Regorafenib;BAY 73-4506
|
4-[4-({[4-氯-3-(三氟甲基)苯基]氨基甲酰}氨基)-3-氟苯氧基]-N-甲基吡啶-2-甲酰胺;REGORAFENIB BAY 73-4506 BAYER HEALTHCARE (SEE ALSO COLORECTAL, LUNG, STOMACH) PHASE II(REGORAFENIB) PHARMACEUTICALS (888) 842-2937WAYNE, NJ;瑞格非尼(FREE BASE);瑞格非尼;瑞格非尼REGORAFENIB;瑞格菲尼;瑞格非尼:瑞格菲尼;瑞戈非尼
|
755037-03-7
|
|
Tubacin
|
HDAC6 抑制劑
|
537049-40-4
|
|
SB-939
|
(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羥基丙烯酰胺;(E)-3-(2-BUTYL-1-(2-(DIETHYLAMINO)ETHYL)-1H-BENZO[D]IMIDAZOL-5-YL)-N-HYDROXYACRYLAMIDE;(2E)-3-[2-丁基-1-[2-(二乙基氨基)乙基]-1H-苯并咪唑-5-基]-N-羥基丙烯酰胺 (SB 939)
|
929016-96-6
|
|
XL518;GDC-0973;RG7420;CobiMetinib
|
[3,4-二氟-2-[(2-氟-4-碘苯基)氨基]苯基][3-羥基-3-(2S)-2-哌啶基-1-氮雜環(huán)丁基]甲酮;克吡替尼
|
934660-93-2
|
|
MG-132
|
MG132,蛋白酶體抑制劑;MG-132;Z-LEU-LEU-LEU-AL;N-[(芐氧基)羰基]-L-亮氨酰-N-[(1S)-1-甲?；?3-甲基丁基]-L-亮氨酰胺
|
133407-82-6
|
|
LY-3154567
|
|
|
|
GDC-0941
|
2-(1H-吲唑-4-基)-6-[[4-(甲基磺?；?-1-哌嗪基]甲基]-4-(4-嗎啉基)噻吩并[3,2-D]嘧啶
|
957054-30-7
|
|
AMG-51
|
|
890019-63-3
|
|
VTX-2337
|
MOTOLIMOD
|
926927-61-9
|
|
VE-822
|
3-[3-[4-[(甲基氨基)甲基]苯基]-5-異惡唑基]-5-[4-[異丙磺?；鵠苯基]-2-吡嗪胺
|
1232416-25-9
|
|
CFI-400945 fumarate
|
1616420-30-4
|
1616420-30-4
|
|
Talarozole
|
N-[4-[(1R)-2-乙基-1-(1H-1,2,4-三唑-1-基)丁基]苯基]-2-苯并噻唑胺;他拉羅唑
|
870093-23-5
|
|
XL-765,SAR245409;XL765;SAR245409;XL765(Voxtalisib)
|
N-[2-[(3,5-二甲氧基苯基)氨基]喹喔啉-3-基]-4-[(4-甲基-3-甲氧基苯基)羰基]氨基苯磺酰胺;N-[2-[(3,5-二甲氧基苯基)氨基]喹喔啉-3-基]-4-[(4-甲基-3-甲氧基苯基)羰基]氨基苯磺酰胺(XL-765, SAR245409)
|
1123889-87-1
|
|
RDEA119;BAY-869766;RefaMetinib;RDEA-119 (BAY-869766);BAY 8697661;RefaMetinib/BAY 8697661
|
瑞法替尼
|
923032-37-5
|
|
TAK-632
|
N-(7-CYANO-6-(4-FLUORO-3-(2-(3-(TRIFLUOROMETHYL)PHENYL)ACETAMIDO)PHENOXY)BENZO[D]THIAZOL-2-YL)CYCLOPROPANECARBOXAMIDE;N-[7-氰基-6-[4-氟-3-[[[3-(三氟甲基)苯基]乙?；鵠氨基]苯氧基]-1,3-苯并噻唑-2-基]環(huán)丙烷甲酰胺;N-[7-氰基-6-[4-氟-3-[[[3-(三氟甲基)苯基]乙?；鵠氨基]苯氧基]-1,3-苯并噻唑-2-基]環(huán)丙烷甲酰胺(TAK-632)
|
1228591-30-7
|
|
E-7090
|
E-7090
|
1622204-21-0
|
|
Mertansine (DM1)
|
|
|
|
Verteporfin
|
維替泊芬
|
129497-78-5
|
|
YK-4-279
|
4,7-二氯-1,3-二氫-3-羥基-3-[2-(4-甲氧基苯基)-2-氧代乙基]-2H-吲哚-2-酮
|
1037184-44-3
|
|
(+)-JQ-1
|
(S)-(+)-2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮雜卓-6-基)乙酸叔丁酯
|
1268524-70-4
|
|
GSK-126
|
GSK126
|
1346574-57-9
|
|
X-396
|
恩沙替尼
|
1365267-27-1
|
|
Curaxin (CBL-0137)
|
|
|
|
RDEA-436
|
|
|
|
BAY-1082439
|
N-[8-[[(2R)-2-羥基-3-(嗎啉-4-基)丙基]氧基]-7-甲氧基-2,3-二氫咪唑并[1,2-C]喹唑啉-5-基]-2-甲基吡啶-3-甲酰胺
|
1375469-38-7
|
|
SGI-1776
|
N-[(1-甲基-4-哌啶基)甲基]-3-[3-(三氟甲氧基)苯基]-咪唑并[1,2-B]噠嗪-6-胺;N-[(1-甲基-4-哌啶基)甲基]-3-[3-(三氟甲氧基)苯基]咪唑并[1,2-B]吡嗪-6-胺
|
1025065-69-3
|
|
SCH-900776
|
SCH-900776
|
891494-64-7
|
|
AZD9291 mesylate
|
AZD9291(甲磺酸鹽)
|
1421373-66-1
|
|
RO-5126766
|
RO5126766(CH5126766)
|
946128-88-7
|
|
EFT-508
|
6'-[(6-氨基-4-嘧啶基)氨基]-8'-甲基螺[環(huán)己烷-1,3'(2'H)-咪唑并[1,5-A]吡啶]-1',5'-二酮
|
1849590-01-7
|
|
S63845
|
S63845
|
1799633-27-4
|
|
Bortezomib
|
保特佐米;[(1R)-3-甲基-1-[[(2S)-1-氧-3-苯基-2-[(吡嗪甲酰)氨基]丙基]氨基]丁基]-硼酸;硼替佐米;BORTEZOMIB; MG-341; PS-341;硼替佐米/保特佐米;包特左米;保特佐米,硼替佐米;10MG/50MG/1G
|
179324-69-7
|
|
Sapacitabine
|
N-[1-[(2R,3S,4S,5R)-3-氰基-4-羥基-5-(羥甲基)氧雜環(huán)戊-2-基]-2-氧代嘧啶-4-基]十六酰胺
|
151823-14-2
|
|
Sorafenib
|
索拉非尼;4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺;對(duì)甲苯磺酸索拉非尼;索拉菲尼;索+E51拉尼;索拉非尼堿;索拉替尼;索拉菲尼堿
|
284461-73-0
|
|
MK-2260
|
|
|
|
LY-3177833
|
CS-2783
|
1627696-51-8
|
|
BAY-1436032
|
2-[[4-(三氟甲氧基)苯基]氨基]-1-[(1R,5R)-3,3,5-三甲基環(huán)己基]-1H-苯并咪唑-5-丙酸
|
1803274-65-8
|
|
SB-216763
|
3-(2,4-二氯苯基)-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮
|
280744-09-4
|